These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9582603)

  • 1. Reevaluaton of the usefulness of systematic bone scanning in initial staging and follow-up of small cell lung carcinoma, taking into account the serum levels of neuron-specific enolase.
    Gendreau V; Montravers F; Philippe C; Talbot JN
    Int J Biol Markers; 1997; 12(4):148-53. PubMed ID: 9582603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
    Shibayama T; Ueoka H; Nishii K; Kiura K; Tabata M; Miyatake K; Kitajima T; Harada M
    Lung Cancer; 2001 Apr; 32(1):61-9. PubMed ID: 11282430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-specific enolase as a marker of brain metastasis in patients with small-cell lung carcinoma.
    van de Pol M; Twijnstra A; ten Velde GP; Menheere PP
    J Neurooncol; 1994; 19(2):149-54. PubMed ID: 7964990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Tc-99m sestamibi, serum neuron-specific enolase and lactate dehydrogenase as predictors of response to chemotherapy in small cell lung cancer.
    Lim SC; Park KO; Kim YC; Na KJ; Song H; Bom HS
    Cancer Biother Radiopharm; 2000 Aug; 15(4):381-6. PubMed ID: 11041023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay of pro-gastrin-releasing peptide for small cell lung cancer patients in comparison with neuron-specific enolase measurement.
    Yamaguchi K; Aoyagi K; Urakami K; Fukutani T; Maki N; Yamamoto S; Otsubo K; Miyake Y; Kodama T
    Jpn J Cancer Res; 1995 Jul; 86(7):698-705. PubMed ID: 7559089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoradiometric assay of chromogranin A in the diagnosis of small cell lung cancer: comparative evaluation with neuron-specific enolase.
    Giovanella L; Ceriani L; Bandera M; Garancini S
    Int J Biol Markers; 2001; 16(1):50-5. PubMed ID: 11288956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum neuron-specific enolase and immunohistochemical markers of neuroendocrine differentiation in lung cancer.
    O'Shea P; Cassidy M; Freaney R; McCarthy P; Fennelly J
    Ir J Med Sci; 1995 Jan; 164(1):31-6. PubMed ID: 7890531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuron-specific enolase and lung cancer.
    Karnak D; Beder S; Kayacan O; Ibiş E; Oflaz G
    Am J Clin Oncol; 2005 Dec; 28(6):586-90. PubMed ID: 16317269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of serum pro-gastrin-releasing peptide as a predictor of relapse of small cell lung cancer: comparative evaluation with neuron-specific enolase and carcinoembryonic antigen.
    Niho S; Nishiwaki Y; Goto K; Ohmatsu H; Matsumoto T; Hojo F; Ohe Y; Kakinuma R; Kodama T
    Lung Cancer; 2000 Mar; 27(3):159-67. PubMed ID: 10699689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neuron-specific enolase as a tumor marker in the diagnosis and follow-up of small-cell lung cancer.
    Pinson P; Joos G; Watripont P; Brusselle G; Pauwels R
    Respiration; 1997; 64(1):102-7. PubMed ID: 9044484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer.
    Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R
    Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Normal serum neuron specific enolase (NSE) value after the first cycle of chemotherapy: an early predictor of complete response and survival in patients with small cell lung carcinoma.
    Fizazi K; Cojean I; Pignon JP; Rixe O; Gatineau M; Hadef S; Arriagada R; Baldeyrou P; Comoy E; Le Chevalier T
    Cancer; 1998 Mar; 82(6):1049-55. PubMed ID: 9506348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of neuron specific enolase in early detection of relapse in small cell lung carcinoma.
    van Zandwijk N; Jassem E; Bonfrer JM; van Tinteren H
    Eur J Cancer; 1990 Mar; 26(3):373-6. PubMed ID: 2162690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A more objective staging of advanced prostate cancer--routine recognition of malignant endocrine structures: the assessment of serum TPS, PSA, and NSE values.
    Tarle M; Frković-Grazio S; Kraljić I; Kovacić K
    Prostate; 1994; 24(3):143-8. PubMed ID: 7509485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum neuron-specific enolase (S-NSE) in progressive small-cell lung cancer (SCLC).
    Jørgensen LG; Osterlind K; Hansen HH; Cooper EH
    Br J Cancer; 1994 Oct; 70(4):759-61. PubMed ID: 7917935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of serum neuron-specific enolase as a predictor of relapse of small cell lung cancer.
    Nitta T; Fukuoka M; Masuda N; Kusunoki Y; Matsui K; Kudoh S; Hirashima T; Yana T; Ito K; Takada M
    Jpn J Clin Oncol; 1995 Oct; 25(5):179-83. PubMed ID: 7474404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine and cytokeratin serum markers as prognostic determinants of small cell lung cancer.
    Pujol JL; Quantin X; Jacot W; Boher JM; Grenier J; Lamy PJ
    Lung Cancer; 2003 Feb; 39(2):131-8. PubMed ID: 12581564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does iliac crest bone marrow biopsy compare with imaging in the detection of bone metastases in small cell lung cancer?
    Perrin-Resche I; Bizais Y; Buhe T; Fiche M
    Eur J Nucl Med; 1993 May; 20(5):420-5. PubMed ID: 8390936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA 15-3 and bone scintigraphy in the follow-up of breast cancer.
    Younsi N; Montravers F; Philippe C; Seddiki M; Uzan S; Izrael V; Talbot JN
    Int J Biol Markers; 1997; 12(4):154-7. PubMed ID: 9582604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.